A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high‐grade glioma-Reference-Cited by-同舟云学术

A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high‐grade glioma

Published:2020-04-14 Issue:6 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Su Jack Meng‐Fen¹^ORCID,Murray Jeffrey C.²,McNall‐Knapp Rene Y.³,Bowers Daniel C.⁴,Shah Shafqat⁵,Adesina Adekunle M.⁶,Paulino Arnold C.⁷^ORCID,Jo Eunji⁸,Mo Qianxing⁸,Baxter Patricia A.¹,Blaney Susan M.¹

Affiliation:

1. Texas Children's Cancer CenterBaylor College of Medicine Houston Texas

2. Cook Children's Medical Center Fort Worth Texas

3. Department of PediatricsThe University of Oklahoma Health Sciences Center Oklahoma City Oklahoma

4. Children's Medical Center/The University of Texas Southwestern Medical Center Dallas Texas

5. The University of Texas Health Science CenterDepartment of Pediatric Hematology‐Oncology San Antonio Texas

6. Texas Children's HospitalDepartment of Pathology Houston Texas

7. The University of Texas MD Anderson Cancer Center Houston Texas

8. Dan L Duncan Cancer CenterDepartment of MedicineBiostatistics and Bioinformatics Houston Texas

Funder

Genentech

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28283

Reference35 articles.

1. Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group

2. The influence of central review on outcome associations in childhood malignant gliomas: Results from the CCG-945 experience

3. Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas

4. A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: A report from the Pediatric Brain Tumor Consortium

5. Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update on H3K27M-altered Diffuse Midline Glioma: Diagnostic and Therapeutic Challenges in Clinical Practice;Practical Radiation Oncology;2024-09

2. Current immunotherapeutic approaches to diffuse intrinsic pontine glioma;Frontiers in Genetics;2024-05-07

3. Safety of Off-Label Use of Anticancer Drugs in Oncology;Creative surgery and oncology;2024-04-18

4. Radiotherapy plus temozolomide with or without anlotinib in H3K27M‐mutant diffuse midline glioma: A retrospective cohort study;CNS Neuroscience & Therapeutics;2024-04

5. Hypofractionated re‐irradiation for diffuse intrinsic pontine glioma;Pediatric Blood & Cancer;2024-03-02